A 72-year-old woman with chronic heart failure (ejection fraction 35%) and hypertension presents with nausea, headache, and mild confusion for 2 days. She denies polydipsia or polyuria. On examination, she is euvolemic with no peripheral edema. Blood pressure is 135/88 mmHg. Laboratory results: Na⁺ 124 mEq/L, K⁺ 4.2 mEq/L, creatinine 1.2 mg/dL (baseline 1.0 mg/dL), BUN 28 mg/dL, urine osmolality 520 mOsm/kg, serum osmolality 256 mOsm/kg, and urine Na⁺ 18 mEq/L. Which of the following is the most likely diagnosis?

Explanation

## Diagnosis: Euvolemic Hyponatremia due to SIADH ### Clinical Context and Differential Diagnosis **Key Point:** Hyponatremia classification depends critically on volume status assessment. This patient is explicitly described as **euvolemic** with no peripheral edema — this is the pivotal finding that drives the diagnosis toward SIADH, not hypervolemic hyponatremia from heart failure. ### Diagnostic Approach: Volume Status Assessment | Parameter | Finding | Interpretation | |-----------|---------|----------------| | **Volume status** | Euvolemic, no edema, BP 135/88 mmHg | Rules out hypervolemic and hypovolemic states | | **Serum osmolality** | 256 mOsm/kg | Hypoosmolar — confirms true hyponatremia | | **Urine osmolality** | 520 mOsm/kg | Inappropriately concentrated (>100 mOsm/kg in setting of hypo-osmolality) | | **Urine Na⁺** | 18 mEq/L | Borderline; consistent with SIADH especially in context of low-salt diet or mild diuretic effect | | **Symptoms** | Nausea, headache, mild confusion | Classic neurological manifestations of hyponatremia | | **No polydipsia/polyuria** | Absent | Argues against primary polydipsia or diabetes insipidus | ### Why SIADH Is the Correct Diagnosis **High-Yield:** The diagnostic criteria for SIADH (Schwartz-Bartter criteria) include: 1. **Hypoosmolality** (serum osmolality < 275 mOsm/kg) ✓ — 256 mOsm/kg 2. **Inappropriately concentrated urine** (urine osmolality > 100 mOsm/kg) ✓ — 520 mOsm/kg 3. **Clinical euvolemia** (no edema, no orthostasis, normal BP) ✓ 4. **Urine Na⁺ > 20–40 mEq/L** in the absence of diuretics — here 18 mEq/L is borderline but consistent in context 5. **Normal renal, adrenal, and thyroid function** (implied by clinical context) The patient's **euvolemic status** is the single most important distinguishing feature. Heart failure causing hypervolemic hyponatremia would present with signs of fluid overload (peripheral edema, elevated JVP, pulmonary crackles) — none of which are present here. Patients with known heart failure CAN develop SIADH from causes unrelated to their cardiac disease (e.g., medications such as SSRIs, carbamazepine, or pulmonary/CNS pathology). ### Why the Other Options Are Incorrect | Option | Reason Incorrect | |--------|-----------------| | **A) Nephrotic syndrome** | No proteinuria mentioned, no hypoalbuminemia, no edema — nephrotic syndrome would present with massive proteinuria and hypoalbuminemia | | **C) Hypervolemic HF** | Patient has **no peripheral edema**, is explicitly euvolemic — hypervolemic hyponatremia from decompensated HF requires clinical signs of fluid overload such as edema, elevated JVP, and pulmonary crackles | | **D) Hypovolemic hyponatremia (diuretics)** | Patient is euvolemic; hypovolemia would show low BP, tachycardia, elevated BUN/Cr ratio >20, and urine Na⁺ typically <10 mEq/L | **Clinical Pearl:** The volume status on examination — not the underlying diagnosis — determines the category of hyponatremia. A euvolemic patient with heart failure and hyponatremia should be diagnosed with SIADH, not hypervolemic hyponatremia. The concentrated urine (520 mOsm/kg) in the setting of low serum osmolality (256 mOsm/kg) is the hallmark of "inappropriate" ADH activity. ### Pathophysiology of SIADH 1. **Inappropriate ADH secretion** (from CNS, pulmonary, or drug-related causes) → excess free water reabsorption in collecting duct 2. **Dilutional hyponatremia** with mildly expanded extracellular volume (but not enough to cause edema) 3. **Pressure natriuresis** from mild volume expansion → urine Na⁺ elevated (natriuresis maintains euvolemia) 4. **Urine remains concentrated** despite low serum osmolality — the hallmark of SIADH ### Management of SIADH 1. **Fluid restriction (800–1000 mL/day):** First-line treatment 2. **Treat underlying cause:** Identify and remove offending drugs, treat CNS/pulmonary pathology 3. **Hypertonic saline (3% NaCl):** Reserved for severe symptomatic hyponatremia (seizures, coma) 4. **Vasopressin receptor antagonists (vaptans):** Tolvaptan or conivaptan for refractory SIADH 5. **Demeclocycline:** Second-line if fluid restriction fails (induces nephrogenic DI) **High-Yield:** Correction rate for hyponatremia must not exceed **8–10 mEq/L per 24 hours** to avoid osmotic demyelination syndrome (central pontine myelinolysis). [cite: Harrison's Principles of Internal Medicine, 21e, Ch. 297; Schwartz WB et al., Am J Med 1957; KD Tripathi Essentials of Medical Pharmacology, 8e]